CANADIAN MULTIDISCIPLINARY
HEPATOCELLULAR CARCINOMA CONFERENCE
Friday, May 12, 2023
Please join us for the 2nd CANADIAN MULTIDISCIPLINARY HEPATOCELLULAR CARCINOMA
CONFERENCE (CMHCC) taking place on Friday May 12, 2023 at the Yorkville Royal Sonesta, Toronto.
This informative conference provides a unique opportunity for attendees to participate in presentations from international experts in the field of Multidisciplinary Hepatocellular Carcinoma. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients.
We are looking forward to seeing everyone in person for this dynamic and educational event!
CMHCC Chairs
Laura Dawson, MD, FRCPC, FASTRO, University of Toronto
Rachel Goodwin, MSc, MD, FRCPC, University of Ottawa
Brandon Meyers, MSc, MD, FRCPC, McMaster University
Vincent Tam, MD, FRCPC, University of Calgary
Learning Objectives:
Early-Stage Disease
-Establish principles of non-surgical techniques for curative intent management
-Review the evidence of liver transplant, and aspects of patient selection
-Examine the data on surgical management of early stage HCC a
Intermediate Stage Disease
-Review the evidence available in defining what is TACE refractory disease and
what other options are
-Examine the data on systemic therapy in intermediate stage HCC
-Evaluate both the strengths and limitations of the BCLC staging system
Advanced Stage Disease
-Review the data on biomarker development in the management of HCC
-Review the existing data on current stem of therapy for advanced HCC as well as future systemic therapy options
-Create a form of open discussion and cross disciplinary knowledge translation
Target Audience
Medical Oncologists, Radiation Oncologists, Interventional Radiologists, Surgical Oncologists Hepatologists, Internists, as well as Residents, Nurse Practitioners and Pharmacists, with an interest in HCC
Accreditation Statement:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This activity was approved by the Canadian Association of Medical Oncologists for a maximum of 6 hours.